About Vapi Pharmaceuticals LLP
Data last updated:
Vapi Pharmaceuticals LLP is a limited liability partnership (LLP) based in Pardi, Gujarat, India. It operates in the industrial packaging solutions segment of the packaging sector. It was incorporated on 09 February 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAD-3339. Its GSTIN is 24AALFD1686J1Z7 (Gujarat). The LLP holds 2 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹22 Cr. It is led by designated partners including Banjul Ashok Shah and Ashokkumar Harakhchand Shah.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Pardi, Gujarat.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹31.99 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹70.34 Lakh (net margin 2.2%) and EBITDA of ₹2.53 Cr (EBITDA margin 7.9%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
The LLP has about 42 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹45.71 Cr and satisfied charges of ₹17.13 Cr on record. Court records list 1 case involving the LLP, including 1 filed by the LLP; 1 case is pending.
For more details, the LLP can be reached via its website damanganga.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA 1109 11th Floor Sonorous Building, Opposite Circuit House, Pardi, Gujarat, India – 396191
- IndustryPackaging, Industrial Packaging Solutions
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Vapi Pharmaceuticals LLP FY 2025 filings available
Vapi Pharmaceuticals LLP reported revenue of ₹31.99 Cr (down 28% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Vapi Pharmaceuticals LLP
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 28% fall in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vapi Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹70.34 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vapi Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Vapi Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Vapi Pharmaceuticals LLP
Vapi Pharmaceuticals has 3 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Banjul Ashok Shah Also directs: Vapi Commercial Enterprises Private Limited, Lakshachandi & Associates LLP, Variflex Packaging Solutions LLP and 3 more | Designated Partner | 18 May 2015 | 11 Years 4 Months | Current |
| Ashokkumar Harakhchand Shah Also directs: Vapi Commercial Enterprises Private Limited | Designated Partner | 09 Feb 2015 | 11 Years 7 Months | Current |
| Rajendrakumar Kantibhai Parmar | Designated Partner | 11 Mar 2025 | 1 Years 6 Months | Current |
Ownership and Shareholding of Vapi Pharmaceuticals LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vapi Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2025 | Icici Bank Limited | ₹17.5 Cr | Open |
| 21 Dec 2023 | Icici Bank Limited | ₹11.34 Cr | Open |
| 21 Dec 2023 | Icici Bank Limited | ₹87 Lakh | Open |
| 28 Dec 2020 | Icici Bank Limited | ₹3 Cr | Open |
| 08 Mar 2019 | Icici Bank Limited | ₹13 Cr | Open |
Total charge records: 7 View all charges
Legal Cases of Vapi Pharmaceuticals LLP
Vapi Pharmaceuticals LLP has 1 court case on record: 1 filed by Vapi Pharmaceuticals. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Special civil application | Filed by the company against State of Gujarat | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Vapi Pharmaceuticals LLP
Vapi Pharmaceuticals LLP has a workforce of 42 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vapi Pharmaceuticals LLP
Vapi Pharmaceuticals LLP has 7 designated partner changes on record since 2015: 3 appointments and 4 cessations. The latest: Rajendrakumar Kantibhai Parmar was appointed as Designated Partner on 11 Mar 2025.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vapi Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vapi Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vapi Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vapi Pharmaceuticals LLP
Vapi Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AALFD1686J1Z7 | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vapi Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vapi Pharmaceuticals LLP
Vapi Pharmaceuticals is an active limited liability partnership based in Pardi, Gujarat, India. The LLP works in industrial packaging solutions, within the packaging industry. It was incorporated on 09 February 2015 (11+ years old) and is registered under LLPIN AAD-3339.
Vapi Pharmaceuticals reported revenue of ₹31.99 Cr for FY 2023 (down 28% YoY).
Vapi Pharmaceuticals has 3 current designated partners:
- Banjul Ashok Shah - Designated Partner
- Ashokkumar Harakhchand Shah - Designated Partner
- Rajendrakumar Kantibhai Parmar - Designated Partner
Vapi Pharmaceuticals reported a net profit of ₹70.34 Lakh (net margin 2.2%) and EBITDA of ₹2.53 Cr (EBITDA margin 7.9%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vapi Pharmaceuticals is -3% over three years and -2% over five years. In the latest year (FY 2023) revenue fell 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vapi Pharmaceuticals is 24AALFD1686J1Z7, registered in Gujarat. The LLP has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Vapi Pharmaceuticals is AAD-3339. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Vapi Pharmaceuticals has 1 court case on record: 1 filed by the LLP. 1 is pending.
Vapi Pharmaceuticals was incorporated on 09 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Rajendrakumar Kantibhai Parmar was appointed as Designated Partner on 11 Mar 2025. Ashokkumar Harakhchand Shah ceased to be Partner on 23 Nov 2022. Priyesh Prakash Shah ceased to be Designated Partner on 15 Nov 2022. Vapi Pharmaceuticals has 7 designated partner changes on record in total.